Log In
Print
BCIQ
Print
Print this Print this
 

aldoxorubicin (formerly DOXO-EMCH, INNO-206)

  Manage Alerts
Collapse Summary General Information
Company CytRx Corp.
Description6-maleimidocaproyl hydrazone prodrug of doxorubicin
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today